Cargando…

Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery

Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease with unknown etiology that can be characterized by the presence of demyelinated lesions. Prevailing treatment protocols in MS rely on the modulation of the inflammatory process but do not impact disease progression. Remyeli...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Schaik, Pauline E. M., Zuhorn, Inge S., Baron, Wia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368816/ https://www.ncbi.nlm.nih.gov/pubmed/35955549 http://dx.doi.org/10.3390/ijms23158418

Ejemplares similares

MMP7 cleaves remyelination‐impairing fibronectin aggregates and its expression is reduced in chronic multiple sclerosis lesions
por: Wang, Peng, et al.
Publicado: (2018)

Macroglial diversity: white and grey areas and relevance to remyelination
por: Werkman, Inge L., et al.
Publicado: (2020)

The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)

Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination
por: Lentferink, Dennis H., et al.
Publicado: (2018)

TLR3 agonists induce fibronectin aggregation by activated astrocytes: a role of pro-inflammatory cytokines and fibronectin splice variants
por: Werkman, Inge, et al.
Publicado: (2020)

Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019)

Remyelination varies between and within lesions in multiple sclerosis following bexarotene
por: Brown, J. William L., et al.
Publicado: (2022)

7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions
por: Kolb, Hadar, et al.
Publicado: (2021)

A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis
por: Rahmanzadeh, Reza, et al.
Publicado: (2022)

CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial
por: Gudi, Viktoria, et al.
Publicado: (2023)

Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
por: Mohan, Hema, et al.
Publicado: (2014)

Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier
por: Georgieva, Julia V., et al.
Publicado: (2014)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
por: Podbielska, Maria, et al.
Publicado: (2013)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Jolanda Münzel, E., et al.
Publicado: (2013)

Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
por: Leo, Heinig, et al.
Publicado: (2022)

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)

Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure
por: Scalabrino, Giuseppe
Publicado: (2022)

Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis
por: Voskuhl, Rhonda R., et al.
Publicado: (2019)

Lesion stage-dependent causes for impaired remyelination in MS
por: Heß, Katharina, et al.
Publicado: (2020)

Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis
por: Brown, Robert A., et al.
Publicado: (2014)

Erratum to: Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Münzel, E. Jolanda, et al.
Publicado: (2013)

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
por: Bodini, Benedetta, et al.
Publicado: (2016)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
por: Al Nimer, Faiez, et al.
Publicado: (2016)

Correlated Heterospectral Lipidomics for Biomolecular Profiling of Remyelination in Multiple Sclerosis
por: Bergholt, Mads S., et al.
Publicado: (2017)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines
por: Aliyandi, Aldy, et al.
Publicado: (2020)

The EIIIA domain from astrocyte‐derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination
por: Stoffels, Josephine M. J., et al.
Publicado: (2014)

Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages
por: Sikkema, Arend H., et al.
Publicado: (2018)

Quantitative magnetic resonance imaging reflects different levels of histologically determined myelin densities in multiple sclerosis, including remyelination in inactive multiple sclerosis lesions
por: Wiggermann, Vanessa, et al.
Publicado: (2023)

The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier
por: Wei, Shuang-Shuang, et al.
Publicado: (2023)

An unmet clinical need: roads to remyelination in MS
por: Göttle, Peter, et al.
Publicado: (2019)

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination
por: Schultz, Verena, et al.
Publicado: (2017)

The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
por: Ben-Shalom, Ido, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kdjchld00hppccgns7g68ttkro